Influence of nicardipine, nimodipine and flunarizine on the anticonvulsant efficacy of antiepileptics against pentylenetetrazol in mice

被引:37
作者
Gasior, M [1 ]
Kaminski, R [1 ]
Brudniak, T [1 ]
Kleinrok, Z [1 ]
Czuczwar, SJ [1 ]
机构
[1] LUBLIN MED UNIV SCH,DEPT PHARMACOL & TOXICOL,PL-20090 LUBLIN,POLAND
关键词
antiepileptics; flunarizine; nicardipine; nimodipine; calcium channel inhibitors; pentylenetetrazol; seizures;
D O I
10.1007/BF01273360
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Among three calcium channel inhibitors, only nicardipine (10-40 mg/kg) significantly inhibited clonic seizures induced by pentylenetetrazol administered at its CD97 (convulsive dose 97%) of 81 mg/kg, subcutaneously. Nimodipine and flunarizine (both up to 80 mg/kg) did not suppress pentylenetetrazol-induced clonic seizures per se. Co-administration of nicardipine (5 mg/kg) resulted in a significant enhancement of the protective potency of either ethosuximide (50 mg/kg) or valproate (100 mg/kg) against clonic seizures in this test. Similar effects were noted in case of combined treatment of nimodipine (20-40 mg/kg) with these antiepileptics. On the contrary: flunarizine (up to 20 mg/kg) did not modify the anticonvulsive action of these antiepileptic drugs. Moreover, none of the studied calcium channel inhibitors influenced the protective activity of clonazepam (0.01 mg/kg). The antiepileptic drugs, administered alone in above doses, were ineffective against pentylenetetrazol-induced clonic convulsions. In case of ethosuximide and valproate, the motor performance in the chimney test was worsened by co-administration of nimodipine (40 mg/kg). We found no pharmacokinetic interactions (at least in relation to the plasma levels of ethosuximide and valproate) that could explain the observed results. Thus. we conclude that a combination of some calcium channel inhibitors and antiepileptic drugs may provide more efficient protection against experimental seizures which may bear a potential clinical significance.
引用
收藏
页码:819 / 831
页数:13
相关论文
共 42 条
[1]   INTERACTION OF FLUNARIZINE WITH DOPAMINE D2 AND D1 RECEPTORS [J].
AMBROSIO, C ;
STEFANINI, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 197 (2-3) :221-223
[2]  
ASHTON D, 1986, EPILEPSY CALCIUM, P319
[3]  
BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.physiol.51.1.367
[4]   OPEN DOSE-RANGING TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY [J].
BINNIE, CD ;
DEBEUKELAAR, F ;
MEIJER, JWA ;
MEINARDI, H ;
OVERWEG, J ;
WAUQUIER, A ;
VANWIERINGEN, A .
EPILEPSIA, 1985, 26 (05) :424-428
[5]  
BOISSIER J.-R, 1960, MED EXPTL, V3, P81
[6]  
CHANG T, 1989, ANTIEPILEPTIC DRUGS, P671
[7]   INFLUENCE OF CALCIUM-CHANNEL INHIBITORS UPON THE ANTICONVULSANT EFFICACY OF COMMON ANTIEPILEPTICS AGAINST PENTYLENETETRAZOL-INDUCED CONVULSIONS IN MICE [J].
CZUCZWAR, SJ ;
MALEK, U ;
KLEINROK, Z .
NEUROPHARMACOLOGY, 1990, 29 (10) :943-948
[8]   INFLUENCE OF FLUNARIZINE, NICARDIPINE AND NIMODIPINE ON THE ANTICONVULSANT ACTIVITY OF DIFFERENT ANTIEPILEPTIC DRUGS IN MICE [J].
CZUCZWAR, SJ ;
GASIOR, M ;
JANUSZ, W ;
KLEINROK, Z .
NEUROPHARMACOLOGY, 1992, 31 (11) :1179-1183
[9]   EFFECTS OF CALCIUM-CHANNEL INHIBITORS UPON THE EFFICACY OF COMMON ANTIEPILEPTIC DRUGS [J].
CZUCZWAR, SJ ;
CHODKOWSKA, A ;
KLEINROK, Z ;
MALEK, U ;
JAGIELLOWOJTOWICZ, E .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 176 (01) :75-83
[10]  
CZUCZWAR SJ, 1995, PHARM TOXICOL S3, V76, pR17